Liraglutide reduces coronary endothelial cells no-reflow damage through activating MAPK/ERK signaling pathway
Year: 2020
Type: article
Authors: Yi Chen, Chen Liu, Peng Zhou, Jiannan Li, Xiaoxiao Zhao, Ying Wang, Runzhen Chen, Li Song, Hanjun Zhao, Hongbing Yan
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3091978807
